ROSEMARY FISHER: Open Payments
NPI 1093860512 · WAUSEON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 27 payments from 9 companies in 2025. Trend: 2023 $180 · 2024 $106 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $194 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| ABBVIE INC. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, COBENFY, INGREZZA, ARISTADA, FANAPT, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
